Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

CytoDyn Price to Book Ratio 2010-2024 | CYDY

Historical price to book ratio values for CytoDyn (CYDY) over the last 10 years. The current price to book ratio for CytoDyn as of February 04, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
  
CytoDyn Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
0.00 nan
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.243B $0.000B
CytoDyn is a biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies for the treatment and prevention of HIV infection. The Company has one of the leading monoclonal antibodies under development for HIV infection, PRO 140, which has completed Phase 2 clinical trials with demonstrated antiviral activity in humans and is currently in Phase 3 development. PRO 140 blocks the HIV co-receptor CCR5 on T cells, which prevents viral entry. Clinical trial results thus far indicate that PRO 140 does not negatively affect the normal immune functions that are mediated by CCR5. Results from seven Phase 1 and Phase 2 human clinical trials have shown that PRO 140 can significantly reduce viral burden in people infected with HIV. A recent Phase 2b clinical trial demonstrated that PRO 140 can prevent viral escape in patients during several months of interruption from conventional drug therapy.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.104B 29.67
Chugai Pharmaceutical (CHGCY) Japan $71.119B 28.07
Takeda Pharmaceutical (TAK) Japan $42.605B 9.43
Sandoz Group AG (SDZNY) Switzerland $21.019B 0.00
Merck (MKKGY) Germany $19.580B 17.53
Astellas Pharma (ALPMY) Japan $17.518B 16.13
Summit Therapeutics (SMMT) United States $15.855B 0.00
United Therapeutics (UTHR) United States $15.678B 15.42
Neurocrine Biosciences (NBIX) United States $15.371B 40.70
Shionogi (SGIOY) Japan $12.999B 0.00
Orion OYJ (ORINY) Finland $7.681B 21.59
Madrigal Pharmaceuticals (MDGL) United States $7.302B 0.00
Corcept Therapeutics (CORT) United States $7.012B 53.11
Stevanato Group S.p.A (STVN) Italy $6.787B 43.94
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.911B 0.00
Ionis Pharmaceuticals (IONS) United States $5.037B 0.00
Grifols, S.A (GRFS) Spain $4.737B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.331B 6.88
Crinetics Pharmaceuticals (CRNX) United States $3.737B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.829B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.691B 12.19
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.559B 15.30
Centessa Pharmaceuticals (CNTA) United Kingdom $2.231B 0.00
Soleno Therapeutics (SLNO) United States $2.166B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.059B 0.00
Hypermarcas (HYPMY) Brazil $1.957B 0.00
Indivior (INDV) United States $1.641B 6.69
BioCryst Pharmaceuticals (BCRX) United States $1.636B 0.00
Evotec AG (EVO) Germany $1.602B 0.00
Dyne Therapeutics (DYN) United States $1.447B 0.00
Guardian Pharmacy Services (GRDN) United States $1.444B 0.00
Xencor (XNCR) United States $1.279B 0.00
Ardelyx (ARDX) United States $1.270B 0.00
ARS Pharmaceuticals (SPRY) United States $1.265B 0.00
Ocular Therapeutix (OCUL) United States $1.211B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.138B 0.00
Harrow (HROW) United States $1.094B 0.00
Enliven Therapeutics (ELVN) United States $1.068B 0.00
Collegium Pharmaceutical (COLL) United States $1.036B 5.65
Bioventus (BVS) United States $0.867B 27.39
Avadel Pharmaceuticals (AVDL) Ireland $0.761B 0.00
Relay Therapeutics (RLAY) United States $0.748B 0.00
Cronos Group (CRON) Canada $0.726B 0.00
Verve Therapeutics (VERV) United States $0.644B 0.00
USANA Health Sciences (USNA) United States $0.621B 11.51
Elite Pharmaceuticals (ELTP) United States $0.534B 0.00
Xeris Biopharma Holdings (XERS) United States $0.531B 0.00
Akebia Therapeutics (AKBA) United States $0.489B 0.00
ProKidney (PROK) United States $0.481B 0.00
Altimmune (ALT) United States $0.472B 0.00
Oruka Therapeutics (ORKA) United States $0.471B 0.00
Savara (SVRA) United States $0.463B 0.00
Organogenesis (ORGO) United States $0.463B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.461B 0.00
OmniAb (OABI) United States $0.455B 0.00
KalVista Pharmaceuticals (KALV) United States $0.440B 0.00
Siga Technologies (SIGA) United States $0.427B 4.98
Zevra Therapeutics (ZVRA) United States $0.418B 0.00
Tourmaline Bio (TRML) United States $0.412B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.381B 154.64
Ironwood Pharmaceuticals (IRWD) United States $0.374B 0.00
Esperion Therapeutics (ESPR) United States $0.353B 0.00
Korro Bio (KRRO) United States $0.320B 0.00
Aldeyra Therapeutics (ALDX) United States $0.312B 0.00
Aquestive Therapeutics (AQST) United States $0.275B 0.00
4D Molecular Therapeutics (FDMT) United States $0.259B 0.00
Heron Therapeutics (HRTX) United States $0.259B 0.00
Nature's Sunshine Products (NATR) United States $0.257B 15.29
Amylyx Pharmaceuticals (AMLX) United States $0.250B 0.00
Larimar Therapeutics (LRMR) United States $0.245B 0.00
Innate Pharma SA (IPHYF) France $0.243B 0.00
Avita Medical (RCEL) United States $0.239B 0.00
MediWound (MDWD) Israel $0.211B 0.00
Profound Medical (PROF) Canada $0.194B 0.00
Acrivon Therapeutics (ACRV) United States $0.189B 0.00
Lexeo Therapeutics (LXEO) United States $0.180B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.179B 0.00
Aclaris Therapeutics (ACRS) United States $0.177B 0.00
Lyell Immunopharma (LYEL) United States $0.172B 0.00
Nanobiotix S.A (NBTX) France $0.164B 0.00
Silence Therapeutics (SLN) United Kingdom $0.160B 0.00
Inhibikase Therapeutics (IKT) United States $0.157B 0.00
VAXART, INC (VXRT) United States $0.155B 0.00
Nektar Therapeutics (NKTR) United States $0.153B 0.00
Champions Oncology (CSBR) United States $0.152B 0.00
Telomir Pharmaceuticals (TELO) United States $0.144B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.119B 0.00
Cardiol Therapeutics (CRDL) Canada $0.116B 0.00
Cassava Sciences (SAVA) United States $0.115B 0.00
Achieve Life Sciences (ACHV) Canada $0.112B 0.00
Inotiv (NOTV) United States $0.111B 0.00
ElectroCore (ECOR) United States $0.111B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.109B 0.00
Protara Therapeutics (TARA) United States $0.102B 0.00
Metagenomi (MGX) United States $0.101B 0.00
Journey Medical (DERM) United States $0.095B 0.00
Pyxis Oncology (PYXS) United States $0.093B 0.00
Nutriband (NTRB) United States $0.092B 0.00
Fractyl Health (GUTS) United States $0.089B 0.00
Avalo Therapeutics (AVTX) United States $0.088B 0.00
Arch Biopartners (ACHFF) Canada $0.082B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.080B 0.00
AleAnna (ANNA) United States $0.080B 0.00
Karyopharm Therapeutics (KPTI) United States $0.079B 0.00
Galectin Therapeutics (GALT) United States $0.078B 0.00
Assertio Holdings (ASRT) United States $0.077B 20.07
ESSA Pharma (EPIX) Canada $0.076B 0.00
PMV Pharmaceuticals (PMVP) United States $0.073B 0.00
Vivani Medical (VANI) United States $0.070B 0.00
Century Therapeutics (IPSC) United States $0.070B 0.00
Context Therapeutics (CNTX) United States $0.069B 0.00
Regulus Therapeutics (RGLS) United States $0.066B 0.00
Mural Oncology (MURA) Ireland $0.064B 0.00
Unicycive Therapeutics (UNCY) United States $0.064B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.063B 0.00
Prelude Therapeutics (PRLD) United States $0.061B 0.00
OptiNose (OPTN) United States $0.060B 0.00
Gain Therapeutics (GANX) United States $0.057B 0.00
Rafael Holdings (RFL) United States $0.051B 0.00
FibroGen (FGEN) United States $0.049B 0.00
NRx Pharmaceuticals (NRXP) United States $0.047B 0.00
AlloVir (ALVR) United States $0.047B 0.00
Iterum Therapeutics (ITRM) Ireland $0.044B 0.00
SCYNEXIS (SCYX) United States $0.041B 0.00
Tempest Therapeutics (TPST) United States $0.040B 0.00
CASI Pharmaceuticals (CASI) China $0.038B 0.00
Surrozen (SRZN) United States $0.038B 0.00
VYNE Therapeutics (VYNE) United States $0.035B 0.00
Jupiter Neurosciences (JUNS) United States $0.034B 0.00
Scienture Holdings (SCNX) United States $0.034B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.032B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.030B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.030B 0.00
Incannex Healthcare (IXHL) Australia $0.029B 0.00
BioVie (BIVI) United States $0.029B 0.00
PolyPid (PYPD) Israel $0.029B 0.00
Natural Alternatives (NAII) United States $0.027B 0.00
Traws Pharma (TRAW) United States $0.027B 0.00
DURECT (DRRX) United States $0.024B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Vivos Therapeutics (VVOS) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Lipocine (LPCN) United States $0.023B 0.00
Dominari Holdings (DOMH) United States $0.022B 0.00
Mannatech (MTEX) United States $0.022B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.020B 0.00
Carisma Therapeutics (CARM) United States $0.019B 0.00
MEI Pharma (MEIP) United States $0.019B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
Cosmos Health (COSM) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
Relmada Therapeutics (RLMD) United States $0.011B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Klotho Neurosciences (KLTO) United States $0.010B 0.00
Ainos (AIMD) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.010B 0.00
Indaptus Therapeutics (INDP) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Redhill Biopharma (RDHL) Israel $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
BioLineRx (BLRX) Israel $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
ProPhase Labs (PRPH) United States $0.006B 0.00
Viracta Therapeutics (VIRX) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Clearmind Medicine (CMND) Canada $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.005B 0.00
Bio-Path Holdings (BPTH) United States $0.005B 0.00
SciSparc (SPRC) Israel $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.07
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00